Arterra Bioscience (ARBS.MI)
Arterra Bioscience operates in the Biotechnology industry of the Healthcare sector, headquartered in Napoli, NA, IT. The stock last traded at $3.17, up 1.60% on the session, giving a market capitalisation of $20.6M. Its beta of 0.64 implies it has historically moved less than the broad market.
Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by scientific research, concentrating on the discovery and development of a wide range of ingredients and nature-based solutions. The firm's activities encompass the creation of advanced technological frameworks, innovative extraction methodologies, and foundational raw materials, specifically tailored for the beauty, agricultural, and nutritional supplement sectors. Established in 2003, Arterra Bioscience S.p.A. is headquartered in Naples, Italy.